| 產(chǎn)品編號(hào) | bs-2039R |
| 英文名稱(chēng) | Rabbit Anti-GRGDS antibody |
| 中文名稱(chēng) | 抗粘附多肽抗體 |
| 別 名 | Gly-Arg-Gly-Asp-Ser; GRGDS; Synthetic integrin antagonist. |
| 研究領(lǐng)域 | 腫瘤 免疫學(xué) 生長(zhǎng)因子和激素 |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | Human (predicted: Gly-Arg-Gly-Asp-Ser) |
| 產(chǎn)品應(yīng)用 | IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:10000-50000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated GRGDS |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
黏附多肽GRGDS Gly-Arg-Gly-Asp-Ser 黏附多肽GRGDS作用： GRGDS五肽可阻斷細(xì)胞外基質(zhì)與細(xì)胞表面整合素的結(jié)合和粘附，能有效抑制惡性腫瘤的轉(zhuǎn)移,增加腫瘤細(xì)胞之間粘附力或腫瘤細(xì)胞與宿主之間粘附力，GRGDS多肽，可抑制腫瘤細(xì)胞從原發(fā)部位逃逸，從而干預(yù)侵襲和轉(zhuǎn)移的過(guò)程。 |
